Incyte | INCY - Passifs Courants





Passifs Courants Changement Date
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Agenus USD 231.82M 17.42M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 25.5B 547M 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Exelixis USD 361.93M 9.05M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
Merck USD 27.73B 786M 2026-06
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novartis USD 31.75B 374M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06